Home › Funds › Artia Global Partners LP › PALI
Artia Global Partners LP position in PALI
PALISADE BIO INC · Health Care
Artia Global Partners LP reported holding 1,992,367 shares of PALI (PALISADE BIO INC) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.77% of its reported portfolio and ranking #29 among its reported holdings. Artia Global Partners LP has disclosed PALI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's PALI position evolved
Artia Global Partners LP first disclosed a stake in PALI in Q4 2025 at 1,992,367 shares (US$4.7M). Across 3 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,992,367 shares valued at US$4.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.99M | $4.68M | New |
| Q1 2026 | 1.99M | $3.49M | Hold |
| Q2 2026 | 1.99M | $4.16M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PALI and 13F data
PALI (PALISADE BIO INC) is a Health Care company. 113 other funds we track also report a position in PALI — the largest reported positions include Soleus Capital Management, L.P. (US$27.3M), B Group, Inc. (US$23.9M), Octagon Capital Advisors LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PALI
- Soleus Capital Management, L.P. 13.06M sh · $27.30M · Q2 2026
- B Group, Inc. 11.41M sh · $23.86M · Q2 2026
- Octagon Capital Advisors LP 10.28M sh · $21.48M · Q2 2026
- Boxer Capital Management, LLC 4.80M sh · $10.03M · Q2 2026
- Squadron Capital Management LLC 3.00M sh · $6.27M · Q2 2026
- Propel Bio Management, LLC 2.58M sh · $5.40M · Q2 2026
- GREAT POINT PARTNERS LLC 2.28M sh · $4.78M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 2.26M sh · $4.72M · Q2 2026
- HighVista Strategies LLC 2.03M sh · $4.24M · Q2 2026
- PLATINUM INVESTMENT MANAGEMENT LTD 1.73M sh · $3.62M · Q2 2026
- Ally Bridge Group (NY) LLC 1.23M sh · $2.57M · Q2 2026
- Creek Drive Management Group LLC 440.00K sh · $919.60K · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held PALI?
Artia Global Partners LP has disclosed PALI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Artia Global Partners LP's current position in PALI?
As of Q2 2026, Artia Global Partners LP holds 1.99M shares of PALI (PALISADE BIO INC), valued at $4.16M, representing 0.77% of its reported portfolio and ranking #29.
Has Artia Global Partners LP been buying or selling PALI?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in PALI.
Which other funds hold PALI?
Other major institutional holders of PALI include Soleus Capital Management, L.P., B Group, Inc., Octagon Capital Advisors LP, among 113 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.